Abstract:At the early stages of life development, alveoli are colonized by embryonic macrophages, which become resident alveolar macrophages (ResAM) and self-sustain by local division. Genetic and epigenetic signatures and, to some extent, the functions of ResAM are dictated by the lung microenvironment, which uses cytokines, ligand-receptor interactions, and stroma cells to orchestrate lung homeostasis. In resting conditions, the lung microenvironment induces in ResAM a tolerogenic programming that prevents unnecessary and potentially harmful inflammation responses to the foreign bodies, which continuously challenge the airways. Throughout life, any episode of acute inflammation, pneumonia being likely the most frequent cause, depletes the pool of ResAM, leaving space for the recruitment of inflammatory monocytes that locally develop in monocyte-derived alveolar macrophages (InfAM). During lung infection, the local microenvironment induces a temporary inflammatory signature to the recruited InfAM to handle the tissue injury and eliminate the pathogens. After a few days, the recruited InfAM, which locally self-sustain and develop as new ResAM, gain profibrotic functions required for tissue healing. After the complete resolution of the infectious episode, the functional programming of both embryonic and monocyte-derived ResAM remains altered for months and possibly for the entire life. Adult lungs thus contain a wide diversity of ResAM since every infection brings new waves of InfAM which fill the room left open by the inflammatory process. The memory of these innate cells called trained immunity constitutes an immunologic scar left by inflammation, notably pneumonia. This memory of ResAM has advantages and drawbacks. In some cases, lung-trained immunity offers better defense capacities against autoimmune disorders and the long-term risk of infection. At the opposite, it can perpetuate a harmful process and lead to a pathological state, as is the case among critically ill patients who have immune paralysis and are highly susceptible to hospital-acquired pneumonia and acute respiratory distress syndrome. The progress in understanding the kinetics of response of alveolar macrophages (AM) to lung inflammation is paving the way to new treatments of pneumonia and lung inflammatory process.

Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting

The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis

Progress in Alveolar Macrophages

Alveolar Macrophages: Adaptation to Their Anatomic Niche during and after Inflammation

Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection

Macrophage Dysfunction in Respiratory Disease

Shaping of the alveolar landscape by respiratory infections and long-term consequences for lung immunity

The Role of Macrophages in the Pathogenesis of ALI/ARDS

[Advances on physiology and pathology of subpopulations of macrophages in the lung tissue]

Dissecting metabolic landscape of alveolar macrophage

Resident macrophages of the lung and liver: The guardians of our tissues

Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis

The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure

Airway macrophage glycolysis controls lung homeostasis and responses to aeroallergen

The role of alveolar macrophages in viral respiratory infections and their therapeutic implications

Macrophages in Lung Injury, Repair, and Fibrosis

Alveolar Macrophages and Acute Lung Injury

Macrophages in Lung Repair and Fibrosis

The Aging Microenvironment Shapes Alveolar Macrophage Identity in Aging

Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury

Alveolar macrophage modulation via the gut–lung axis in lung diseases